Differential Effects of Acetylcholinesterase Inhibitors on Clinical Responses and Cerebral Blood Flow Changes in Patients with Alzheimer's Disease: A 12-Month, Randomized, and Open...

by Soichiro Shimizu, Hidekazu Kanetaka, Daisuke Hirose, Hirohumi Sakurai, Haruo Hanyu
Published 2015-04-01

Cerebrospinal fluid analysis in individuals with diabetes-related dementia

by Hidekazu Kanetaka, Raita Fukasawa, Soichiro Shimizu, Naohito Takenoshita, Haruo Hanyu
Published 2017-09-01

Sarcopenia and Muscle Functions at Various Stages of Alzheimer Disease

by Yusuke Ogawa, Yoshitsugu Kaneko, Tomohiko Sato, Soichiro Shimizu, Hidekazu Kanetaka, Haruo Hanyu
Published 2018-08-01

A Longitudinal SPECT Study of Different Patterns of Regional Cerebral Blood Flow in Alzheimer’s Disease with or without Diabetes

by Kentaro Hirao, Haruo Hanyu, Tomohiko Sato, Hidekazu Kanetaka, Soichiro Shimizu, Hirofumi Sakurai, Toshihiko Iwamoto
Published 2011-01-01

Differentiating Mild Cognitive Impairment, Alzheimer's Disease, and Dementia With Lewy Bodies Using Cingulate Island Sign on Perfusion IMP-SPECT

by Hidekazu Kanetaka, Soichiro Shimizu, Yuta Inagawa, Daisuke Hirose, Naoto Takenoshita, Hirofumi Sakurai, Haruo Hanyu
Published 2020-11-01

Efficacy of Olfactory and Pareidolia Tests Compared With That of Indicative Biomarkers in Diagnosis of Dementia With Lewy Bodies

by Yuta Inagawa, Hidekazu Kanetaka, Akito Tsugawa, Shu Sakurai, Shuntaro Serisawa, Soichiro Shimizu, Hirofumi Sakurai, Haruo Hanyu
Published 2020-09-01

Role of Neuroimaging as a Biomarker for Neurodegenerative Diseases

by Soichiro Shimizu, Daisuke Hirose, Hirokuni Hatanaka, Naoto Takenoshita, Yoshitsugu Kaneko, Yusuke Ogawa, Hirofumi Sakurai, Haruo Hanyu
Published 2018-04-01

A Novel LRRK2 Variant p.G2294R in the WD40 Domain Identified in Familial Parkinson’s Disease Affects LRRK2 Protein Levels

by Jun Ogata, Kentaro Hirao, Kenya Nishioka, Arisa Hayashida, Yuanzhe Li, Hiroyo Yoshino, Soichiro Shimizu, Nobutaka Hattori, Yuzuru Imai
Published 2021-04-01